Treatment of cancer pain with transdermal fentanyl

The Lancet Oncology
Geoffrey K Gourlay

Abstract

Pain is a feature of many cancers, particularly in the advanced stages at which the palliative care approach to symptom control achieves the best outcomes. The holistic approach generally dictates that any treatment of the cancer per se has symptom control as the primary objective at this advanced stage. Pain, which invariably increases with disease progression, is treated with opioids and adjuvant analgesic drugs together with physical therapies. Orally administered opioid drugs are used preferentially because of cost and convenience, but other routes of administration (subcutaneous, rectal, spinal) are also possible. More recently, transdermal fentanyl has been evaluated in the treatment of moderate to severe cancer pain. The rate of fentanyl absorption is constant (after a lag period), and the dose is altered by increasing or decreasing the area of skin covered by the patch (size and/or number of patches). The dosing interval for these systems is generally 3 days. The extent of pain relief provided by transdermal fentanyl and sustained release morphine formulations is similar, with quality-of-life instruments showing no consistent preference for either formulation. Open studies have suggested a lower risk of constipation. Tr...Continue Reading

References

Apr 1, 1992·Journal of Pain and Symptom Management·S K GuptaS S Hwang
Apr 1, 1992·Journal of Pain and Symptom Management·K A Lehmann, D Zech
Jun 1, 1989·Anesthesiology·J R VarvelD R Stanski
Feb 1, 1995·Journal of Pain and Symptom Management·G W Hanks, M T Fallon
Jan 1, 1994·Gerontology·M T HoldsworthR Reynolds
Aug 1, 1993·Anesthesia and Analgesia·P G RoseM V Boswell
Jan 1, 1993·Anesthesiology·R K PortenoyK M Foley
Sep 26, 1997·Southern Medical Journal·W E HardwickP A Palmisano
May 2, 1998·Journal of Pain and Symptom Management·B DonnerM Raber
Sep 16, 1998·Journal of Pain and Symptom Management·P A SloanH Hays
Jul 7, 1999·Lancet·H McQuay
Sep 15, 1999·Journal of Pain and Symptom Management·R HuntM Brooksbank
Feb 11, 2000·Clinical Pharmacokinetics·S GrondK A Lehmann
Mar 4, 2000·The Journal of Emergency Medicine·R J RobergeR Mrvos
Mar 4, 2000·European Journal of Pain : EJP·U E Kongsgaard, P Poulain
Sep 16, 2000·Journal of Pain and Symptom Management·G ZeppetellaS Collins

❮ Previous
Next ❯

Citations

Oct 31, 2009·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Lewis Nelson, Robert Schwaner
Oct 14, 2004·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Paul Schriek
Jul 13, 2005·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Florian Strasser
Sep 28, 2005·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Lene JarlbaekMorten Andersen
Dec 1, 2005·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Eric Prommer
Mar 10, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Do-Yeun KimSi-Young Kim
Mar 11, 2004·Journal of Pain and Symptom Management·Carla RipamontiFranco De Conno
Apr 16, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Honggang ZhuS Kevin Li
Jan 22, 2003·Peptides·Richard J Bodnar, Maria M Hadjimarkou
Oct 8, 2009·Journal of Palliative Medicine·Eric Prommer
Jul 11, 2003·Lancet·Alessandro ChinellatoPietro Giusti
Dec 6, 2012·Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA·Seyyed Mohammad Jalil AbrishamHamid Pahlavanhosseini
Feb 18, 2006·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Carla RipamontiFranco De Conno
Mar 31, 2006·Annals of Hematology·Pasquale NiscolaPaolo De Fabritiis
Oct 2, 2009·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Ramune JacobsenLona Christrup
Apr 26, 2006·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Yutaka TsutsumiNobuo Masauzi
Feb 4, 2012·The Lancet Oncology·Augusto CaraceniUNKNOWN European Association for Palliative Care (EAPC)
Feb 4, 2009·Critical Reviews in Oncology/hematology·Carla Ripamonti, Elena Bandieri
Jul 17, 2008·Supportive Cancer Therapy·Sriram YennurajalingamEduardo Bruera
Jul 12, 2008·Journal of Clinical Anesthesia·Vincent MinvilleOlivier Fourcade
Jan 8, 2008·Journal of Pain and Symptom Management·Judith A PaiceMichael J Avram
Aug 11, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Isabel Diaz del ConsueloYves Jacques
Mar 14, 2007·The Journal of Pain : Official Journal of the American Pain Society·Boris ZernikowBrian Anderson
Dec 13, 2006·Pain Practice : the Official Journal of World Institute of Pain·Mikhail FukshanskyAllen W Burton
Aug 26, 2003·European Journal of Pain : EJP·Joy R Ross, Columba Quigley
Apr 23, 2009·International Journal of Urology : Official Journal of the Japanese Urological Association·Tetsuya FujimuraYukio Homma
Sep 20, 2005·Biological Psychiatry·Adrie W BruijnzeelMark Gold
Jun 8, 2002·Paediatric Respiratory Reviews·T LancasterS Shepperd
Sep 3, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Shao-Zhi Xing, Ying Zhang
May 16, 2009·Pain·Tarja HeiskanenEija Kalso
Jun 4, 2008·The American Journal of Forensic Medicine and Pathology·Sandra ThomasJoseph P Pestaner
Jun 6, 2020·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Lawrence D JacksonDebbie Selby
Dec 3, 2003·Journal of Pain & Palliative Care Pharmacotherapy·Andreas FreiNiels-Henrik Jensen
Nov 1, 2016·European Journal of Hospital Pharmacy. Science and Practice·Yi Ching YuenNoreen Chan
May 24, 2007·Japanese Journal of Clinical Oncology·Katri Elina Clemens, Eberhard Klaschik
Sep 24, 2004·The Tohoku Journal of Experimental Medicine·Kazuhiko Kotani
Oct 1, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M FallonUNKNOWN ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.